| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG AND COA | |
Heteromer
| 439-865 | 99.76 | 4×COA; 4×MAH; 2×DTT; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | |
Heteromer
| 441-862 | 99.76 | 4×8HI; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | |
Heteromer
| 441-861 | 99.76 | 4×4HI; |
|
| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH COMPACTIN (ALSO KNOWN AS MEVASTATI… | |
Heteromer
| 441-861 | 99.75 | 4×114; 2×ADP; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | |
Heteromer
| 441-861 | 99.76 | 4×3HI; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | |
Heteromer
| 441-861 | 99.76 | 4×9HI; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | |
Heteromer
| 441-861 | 99.76 | 4×6HI; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | |
Heteromer
| 441-860 | 99.76 | 4×SO4; 4×5HI; |
|
| Substituted Pyrazoles as Hepatselective HMG-COA reductase inhibitors | |
Heteromer
| 441-860 | 99.76 | 4×SO4; 4×RIE; |
|
| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN | |
Heteromer
| 442-861 | 99.75 | 5×ADP; 4×117; |
|
| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ROSUVASTATIN (FORMALLY KNOWN AS ZD… | |
Heteromer
| 442-860 | 99.75 | 3×ADP; 4×FBI; |
|
| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH SIMVASTATIN | |
Heteromer
| 442-860 | 99.75 | 5×ADP; 4×SIM; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | |
Heteromer
| 444-861 | 99.75 | 4×882; |
|
| Design and Synthesis of Pyrrole-based, Hepatoselective HMG-CoA Reductase Inhibitors | |
Heteromer
| 444-861 | 99.75 | 4×882; |
|
| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG, COA, AND NADP+ | |
Heteromer
| 462-872 | 99.76 | 4×COA; 4×MAH; 4×NAP; |
|
| Design and synthesis of novel, conformationally restricted HMG-COA reductase inhibitors | | homo-4-mer | 441-866 | 99.76 | 4×SO4; 4×HR2; |
|
| Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors | | homo-4-mer | 441-865 | 99.77 | 4×SO4; 4×7HI; |
|
| Design and synthesis of novel, conformationally restricted HMG-COA reductase inhibitors | | homo-4-mer | 441-861 | 99.76 | 4×SO4; 4×HR1; |
|
| Hepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inh… | | homo-4-mer | 441-861 | 99.76 | 4×RID; |
|
| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH CERIVASTATIN | | homo-4-mer | 442-861 | 99.76 | 6×ADP; 4×116; |
|
| COMPLEX OF CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG-COA | | homo-4-mer | 453-866 | 99.75 | 4×HMG; |
|
| COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH FLUVASTATIN | | homo-4-mer | 462-862 | 99.75 | 4×115; 3×ADP; |
|